Senate Republicans scheduled a confirmation hearing for Dr. Heidi Overton, President Donald Trump's nominee for Food and Drug Administration Commissioner, for Thursday, Sept. 24. Overton, a former White House health policy adviser, will face questions on vaccines, prescription drug approvals and food reform.
Democrats on the committee are expected to press Overton's anti-abortion record against Republican senators up for reelection in 2026. Americans United for Life endorsed her nomination in August.
Anti-abortion advocates hope Overton will use the FDA post to restrict access to mifepristone, the abortion pill at the center of the debate since the Supreme Court overturned Roe v. Wade in 2022.
If confirmed, Overton would immediately enter ongoing litigation between anti-abortion activists and the FDA over telemedicine access to mifepristone. The Biden administration deregulated the drug, eliminating the requirement for in-person screening before and after dispensing.
That change increased medication abortions nationwide, including in states where abortion is otherwise illegal. The U.S. 5th Circuit Court of Appeals heard the case Louisiana v. FDA earlier this month, with Louisiana arguing that the FDA's telemedicine rules harm women and infringe state sovereignty.
Former FDA Commissioner Dr. Marty Makary and Health and Human Services Secretary Robert F. Kennedy Jr. promised Republican senators that the agency would conduct new safety studies on mifepristone. The FDA has not released results.
Holding Overton's hearing 40 days before the 2026 midterms creates political risk for incumbent Republicans. Their support for abortion restrictions could become a campaign liability.
Democrats are expected to argue their Republican colleagues are pursuing a "back-door abortion ban" that would restrict the procedure even in states where it remains legal.
Overton could also face questions about her work on Trump's pro-family agenda, including the Moms.gov website launched this spring. The site includes information about crisis pregnancy centers, which Democrats say amounts to an anti-abortion effort.
